Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial

Trial Profile

Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2017

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Proof of concept; Registrational; Therapeutic Use
  • Acronyms PACE
  • Most Recent Events

    • 30 Nov 2017 Results presented in a RespireRx Pharmaceuticals media release.
    • 30 Nov 2017 According to a RespireRx Pharmaceuticals media release, results from this trial have been published in the journal SLEEP.
    • 08 Sep 2017 According to a RespireRx Pharmaceuticals media release, results from this trial will be presented at the 2017 Rodman & Renshaw Conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top